JPMorgan updated its outlook on Nasdaq OMX Group Inc. (NASDAQ:NDAQ), increasing the price target to $95 from the previous $88, while reaffirming an Overweight rating on the stock. Currently trading at ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

JPMorgan analyst Stephen Tusa Jr. adjusted the price target for Roper Industries (NASDAQ:ROP) upward to $558 from the ...

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

The J.P. Morgan Nasdaq Equity Premium Income ETF (JEPQ) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively-managed fund of US large-cap companies from the ...

Qualcomm (NASDAQ:QCOM) was in focus on Tuesday as J.P. Morgan placed the semiconductor company on a positive Catalyst Watch ...

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan ...

SG Americas Securities LLC cut its stake in iShares J.P. Morgan USD Emerging Markets Bond ETF (NASDAQ:EMB – Free Report) by 24.7% during the 4th quarter, according to its most recent Form 13F ...

Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare ...

Olema Pharmaceuticals will present at the J.P. Morgan Healthcare Conference on ... (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on ...

BRIDGEWATER, N.J., Jan. 2, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first ... will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday ...